Mesoblast(MESO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MESO Mesoblast

Trading 11-03 15:41:39 EST

14.79

+0.25

+1.69%

High15.15	Low14.76	Vol205.56K
Open14.92	D1 Closing14.54	Amplitude2.68%
Mkt Cap1.92B	Tradable Cap1.24B	Total Shares129.69M
T/O3.05M	T/O Rate0.25%	Tradable Shares83.80M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MESO","market":"US","secType":"STK","nameCN":"Mesoblast","latestPrice":14.785,"timestamp":1793738497703,"preClose":14.54,"halted":0,"volume":205555,"delay":0,"changeRate":0.01685006877579099,"floatShares":83804000,"shares":129686277,"eps":-0.444,"marketStatus":"Trading","change":0.245,"latestTime":"11-03 15:41:39 EST","open":14.92,"high":15.15,"low":14.76,"amount":3053872.874045,"amplitude":0.026823,"askPrice":14.79,"askSize":10,"bidPrice":14.78,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-0.444,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793739600000},"marketStatusCode":2,"adr":1,"adrRate":10,"listingDate":1447390800000,"exchange":"NASDAQ","adjPreClose":14.54,"preHourTrading":{"tag":"盘前","latestPrice":14.89,"preClose":14.54,"latestTime":"09:29 EST","volume":1420,"amount":21225.7198,"timestamp":1793716199999,"change":0.35,"changeRate":0.024072,"amplitude":0.013755},"postHourTrading":{"tag":"盘后","latestPrice":14.61,"preClose":14.54,"latestTime":"19:30 EST","volume":639,"amount":9319.13,"timestamp":1793665802736,"change":0.07,"changeRate":0.004814,"amplitude":0.004814},"volumeRatio":0.624352,"impliedVol":0.7323,"impliedVolPercentile":0.5936},"requestUrl":"/m/hq/s/MESO","defaultTab":"news","newsList":[{"id":"2680783734","title":"Mesoblast announces changes, retirement of certain members of its Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2680783734","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680783734?lang=en_us&edition=fundamental","pubTime":"2026-11-02 07:50","pubTimestamp":1793577006,"startTime":"0","endTime":"0","summary":"Mesoblast (MESO) announced rotational changes and retirement of certain members of its Board, and reiterated its intention to add new members with ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mesoblast-announces-changes-retirement-of-certain-members-of-its-board-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mesoblast-announces-changes-retirement-of-certain-members-of-its-board-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680278398","title":"Mesoblast Announces Board Changes Following Ryoncil Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2680278398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2680278398?lang=en_us&edition=fundamental","pubTime":"2026-11-02 07:24","pubTimestamp":1793575473,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) just unveiled an update. Mesoblast announced the retirement of directors William Burns and Philip Krause, who have ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-announces-board-changes-following-ryoncil-launch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-announces-board-changes-following-ryoncil-launch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679258614","title":"Australian Shares Close Higher; Mesoblast Rallies After Posting Revenue Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2679258614","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679258614?lang=en_us&edition=fundamental","pubTime":"2026-10-29 13:30","pubTimestamp":1793251830,"startTime":"0","endTime":"0","summary":"Australian shares closed higher on Thursday, tracking Wall Street gains after the US Federal Reserve decided to leave borrowing costs unchanged on Wednesday even as it flagged elevated inflation.The S","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XAO.AU","XKO.AU","MESO","XJO.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679244185","title":"Mesoblast Says Q1 Net Revenues up 44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679244185","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679244185?lang=en_us&edition=fundamental","pubTime":"2026-10-29 09:17","pubTimestamp":1793236664,"startTime":"0","endTime":"0","summary":"BRIEF-Mesoblast Says Q1 Net Revenues Up 44%Oct 29 (Reuters)-Mesoblast LimitedMSB.AX:Q1 NET REVENUES UP 44%, NET OPERATIONAL CASH SPEND IMPROVED 86% VERSUS PRIOR YEARCASH AT SEPT 30, 2026 US$99 MILLION; Q1 OPERATING CASH SPEND US$2.1 MILLIONFurther company coverage:MSB.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261029:nFWN46E2IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK4139","MSB.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679457694","title":"Press Release: Activity Report for Quarter Ended September 30, 2026 (Appendix 4C)","url":"https://stock-news.laohu8.com/highlight/detail?id=2679457694","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679457694?lang=en_us&edition=fundamental","pubTime":"2026-10-29 08:19","pubTimestamp":1793233140,"startTime":"0","endTime":"0","summary":"NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided its activity report for t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MESO","BK7501","BK7508","MSC","BK4006","BK4139","MSB","MSB.AU","BK4575","BK4022","BK4150","R","BK7067","BK4232"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679487254","title":"Mesoblast - Q1 Net Revenues up 44%, Net Operational Cash Spend Improved 86% vs Prior Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2679487254","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679487254?lang=en_us&edition=fundamental","pubTime":"2026-10-29 06:55","pubTimestamp":1793228148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nFWN46E2IM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK7508","BK7067","BK7501","BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679448080","title":"Mesoblast - Cash at Sept 30, 2026 US$99 Mln; Q1 Operating Cash Spend Us$2.1 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2679448080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679448080?lang=en_us&edition=fundamental","pubTime":"2026-10-29 06:55","pubTimestamp":1793228148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nFWN46E2IM:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK4139","BK7508","MESO","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678163571","title":"State Street Entities Exit Substantial Holder Position in Mesoblast","url":"https://stock-news.laohu8.com/highlight/detail?id=2678163571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678163571?lang=en_us&edition=fundamental","pubTime":"2026-10-26 16:37","pubTimestamp":1793003836,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has provided an update. State Street Corporation, through several global asset management and trust subsidiaries, h...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/state-street-entities-exit-substantial-holder-position-in-mesoblast?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/state-street-entities-exit-substantial-holder-position-in-mesoblast?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","IE00BGHQF748.EUR","LU1894683348.USD","BK4135","LU1883839398.USD","LU1894683264.USD","GABF","TRUF","IE00B3QW5Z07.USD","AMGR","BCFN","BK4585","BK4139","IE0034235188.USD","STT","MESO","LU0061475181.USD","IE00B64PRP62.GBP","KCE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676695387","title":"Mesoblast And 2 Australian Insider Backed Growth Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2676695387","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676695387?lang=en_us&edition=fundamental","pubTime":"2026-10-20 17:40","pubTimestamp":1792489239,"startTime":"0","endTime":"0","summary":"Asian LNG prices recently moved above $30 per unit as shipping risks in the Middle East raised fresh questions about energy security. Australian investors now face a market where reliable growth stories backed by confident insiders can feel scarce. That is why fast growing local companies where management holds meaningful stakes can be compelling. This article highlights three such Australian stocks from our high insider ownership growth shortlist.\nThe three stocks highlighted here offer a...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-and-2-australian-insider-backed-growth-stocks-to-w","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/mesoblast-and-2-australian-insider-backed-growth-stocks-to-w","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XJO.AU","ZYAU.AU","BK7508","GEAR.AU","VAS.AU","MSB.AU","QFN.AU","CDA.AU","IISV.AU","TLX","XKO.AU","OZR.AU","BK7084","BEAR.AU","DACE.AU","IMLC.AU","IOZ.AU","SLF.AU","USD.AU","VAP.AU","TLX.AU","BK7067","BBOZ.AU","QRE.AU","EIGA.AU","IIGF.AU","BK4139","BK7501","MESO","USD","GIVE.AU","E200.AU","OZF.AU","XAO.AU","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676517097","title":"Will Ryoncil Revenue Growth Change Mesoblast Stock Narrative","url":"https://stock-news.laohu8.com/highlight/detail?id=2676517097","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2676517097?lang=en_us&edition=fundamental","pubTime":"2026-10-17 07:35","pubTimestamp":1792193709,"startTime":"0","endTime":"0","summary":"Mesoblast reported Q1 FY26 net revenue of US$28 million from Ryoncil, alongside an 85% improvement in net operating cash spend and a cash balance of US$99 million as at 30 September 2026.\nThe combination of growing Ryoncil sales and lower cash burn gives investors a clearer view of how Mesoblast’s cell therapy model can scale operationally.\nThis article reviews how Mesoblast’s investment narrative is influenced by stronger Ryoncil revenue and improved operating cash discipline.\n\nCompare...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice2-card/1788928698944"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/will-ryoncil-revenue-growth-change-mesoblast-stock-narrative","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-msb/mesoblast-shares/news/will-ryoncil-revenue-growth-change-mesoblast-stock-narrative","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675889551","title":"Mesoblast Says Ryoncil Net Revenue Increased 44% Year Over Year in September Quarter; Shares Hit 52-Week Low","url":"https://stock-news.laohu8.com/highlight/detail?id=2675889551","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675889551?lang=en_us&edition=fundamental","pubTime":"2026-10-16 08:43","pubTimestamp":1792111386,"startTime":"0","endTime":"0","summary":"Mesoblast  reported a 44% increase in net revenue from sales of Ryoncil and an 85% improvement in net operating cash spend for the September quarter compared with a year earlier, according to a Friday filing with the Australian bourse.Net revenue for Ryoncil, a mesenchymal stromal cell therapy, increased to $28 million in the September quarter from $19 million a year earlier, per the filing.The company said September saw the highest number of new patient starts per month, following expected seasonality from summer recess-related treatment scheduling that occurs every July and August.Mesoblast shares fell 10% in recent Friday trade, hitting a 52-week low.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675584803","title":"Mesoblast Updates ASX on October 14 Capital Structure Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2675584803","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2675584803?lang=en_us&edition=fundamental","pubTime":"2026-10-15 19:57","pubTimestamp":1792065456,"startTime":"0","endTime":"0","summary":"Mesoblast ( ($MESO) ) just unveiled an update. On October 14, 2026, Mesoblast Limited lodged a series of new issue announcements with the Australia...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-updates-asx-on-october-14-capital-structure-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-updates-asx-on-october-14-capital-structure-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674829516","title":"Mesoblast Sets Details for 2026 Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2674829516","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674829516?lang=en_us&edition=fundamental","pubTime":"2026-10-12 13:27","pubTimestamp":1791782847,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Mesoblast Limited ( ($AU:MSB) ). Mesoblast Limited has announced details for its 2026 Annual General Meeting, w...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-sets-details-for-2026-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-sets-details-for-2026-annual-general-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MESO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674295118","title":"Mesoblast Files Updated Corporate Governance Statement and ASX Appendix 4G","url":"https://stock-news.laohu8.com/highlight/detail?id=2674295118","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2674295118?lang=en_us&edition=fundamental","pubTime":"2026-10-12 13:17","pubTimestamp":1791782260,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) just unveiled an update. Mesoblast Limited has lodged its updated corporate governance statement for the financial ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-files-updated-corporate-governance-statement-and-asx-appendix-4g?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-files-updated-corporate-governance-statement-and-asx-appendix-4g?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","JSTC","SUSA","EXEQ","HAPI","PEMX","NUSC","ESGV","BK4588","CHRI","ESGA","ESML","CDEI","LOPP","HAPY","ESGY","FDRX","ESG","MDCP","BK4585","SSPX","CVLC","VOTE","NUDV","BK4139","DSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672755327","title":"State Street Group Cuts Mesoblast Stake Below Substantial Holder Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2672755327","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672755327?lang=en_us&edition=fundamental","pubTime":"2026-10-01 17:08","pubTimestamp":1790845721,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has shared an announcement. State Street Corporation, through a group of asset management and trust subsidiaries in...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/state-street-group-cuts-mesoblast-stake-below-substantial-holder-threshold-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/state-street-group-cuts-mesoblast-stake-below-substantial-holder-threshold-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B3QW5Z07.USD","LU0061475181.USD","LU1894683348.USD","IE0034235188.USD","MESO","GABF","BK4585","STT","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU1894683264.USD","BK4135","KCE","BK4588","LU1883839398.USD","TRUF","BK4139","AMGR","BCFN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669437128","title":"Mesoblast Wins FDA Nod for New Potency Assay on Ryoncil Batches","url":"https://stock-news.laohu8.com/highlight/detail?id=2669437128","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669437128?lang=en_us&edition=fundamental","pubTime":"2026-09-24 08:30","pubTimestamp":1790209807,"startTime":"0","endTime":"0","summary":"An announcement from Mesoblast Limited ( ($AU:MSB) ) is now available. Mesoblast has secured U.S. FDA approval for a new T-cell Proliferation Inhib...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mesoblast-wins-fda-nod-for-new-potency-assay-on-ryoncil-batches?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMED","GDOC","LABU","MEDI","TBXU","IEIH","IBB","FRTY","BBP","MRNY","TECB","PINK","MRNX","GNMX","SYNB","XLVX","BK4588","MESO","IDNA","BK4585","PSCH","RSPH","NVIB","IYH","BK4139","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669432383","title":"Mesoblast - Receives FDA Approval for New Potency Assay for Commercial Ryoncil Product","url":"https://stock-news.laohu8.com/highlight/detail?id=2669432383","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669432383?lang=en_us&edition=fundamental","pubTime":"2026-09-24 07:52","pubTimestamp":1790207540,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUEBVRFV4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MSB.AU","BK4139","MESO","BK7501","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669101639","title":"State Street Group Ceases to Be Substantial Holder in Mesoblast","url":"https://stock-news.laohu8.com/highlight/detail?id=2669101639","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669101639?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:57","pubTimestamp":1790153850,"startTime":"0","endTime":"0","summary":"Mesoblast Limited ( ($AU:MSB) ) has shared an announcement. State Street Corporation and several of its asset management subsidiaries have lodged a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/state-street-group-ceases-to-be-substantial-holder-in-mesoblast-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/state-street-group-ceases-to-be-substantial-holder-in-mesoblast-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCFN","BK4139","IE00B64PRP62.GBP","IE0034235188.USD","LU1894683264.USD","IE00BGHQF748.EUR","MESO","STT","BK4585","LU1883839398.USD","TRUF","KCE","IE00B3QW5Z07.USD","LU0061475181.USD","LU1894683348.USD","BK4135","GABF","AMGR","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664331216","title":"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX) and Mesoblast (MESO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664331216","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664331216?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:10","pubTimestamp":1788523832,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNTech SE (BNTX) and Mesoblast (MESO) with bullish...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-and-mesoblast-meso-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-and-mesoblast-meso-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034224299.USD","LU0210637038.USD","LU0499858602.USD","IE0001KFT4U8.USD","LU2065169927.USD","LU2238330802.EUR","SG9999001135.SGD","FDNI","SG9999013460.SGD","XBI","HCSG","LABU","IE00BD6J9T35.USD","LU1770036033.HKD","LU0048573645.USD","BK4551","LU0737861269.HKD","LU2065171311.SGD","SG9999002679.SGD","SG9999004360.SGD","SGXZ58947870.SGD","LU2065170008.USD","LU0979878070.USD","LU2045819591.USD","SE","SG9999005177.SGD","BNTX","LU0572939691.SGD","XLV","LU1839390173.USD","MESO","LU2152927971.USD","SG9999014484.SGD","BK4139","BK4585","SG9999002604.SGD","LU0516422366.SGD","LU1242518931.SGD","BK4554","LU2008162690.USD","LU0175139822.USD","BK4535","LU0348788117.USD","LU0261945553.USD","LU0532188223.SGD","LU0516423091.SGD","SG9999013478.USD","BK4581","LU1861217088.USD","LU2543165471.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663027378","title":"Post-Approval Safety Risks Threaten Mesoblast’s Ryoncil Commercialization in Fragile Pediatric SR-aGVHD Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2663027378","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663027378?lang=en_us&edition=fundamental","pubTime":"2026-08-31 14:07","pubTimestamp":1788156456,"startTime":"0","endTime":"0","summary":"Mesoblast (MESO) has disclosed a new risk, in the Regulation category. Mesoblast faces ongoing risk that post-approval safety findings or real-worl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/post-approval-safety-risks-threaten-mesoblasts-ryoncil-commercialization-in-fragile-pediatric-sr-agvhd-market?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/post-approval-safety-risks-threaten-mesoblasts-ryoncil-commercialization-in-fragile-pediatric-sr-agvhd-market?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MESO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mesoblast.com","stockEarnings":[{"period":"1week","weight":0.1735},{"period":"1month","weight":0.0327},{"period":"3month","weight":-0.0176},{"period":"6month","weight":-0.0803},{"period":"1year","weight":-0.1273},{"period":"ytd","weight":-0.194}],"compareEarnings":[{"period":"1week","weight":-0.0173},{"period":"1month","weight":-0.0228},{"period":"3month","weight":-0.0249},{"period":"6month","weight":0.0249},{"period":"1year","weight":0.1027},{"period":"ytd","weight":0.1029}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. The company offers Remestemcel-L that is in Phase III clinical trials for the treatment of systemic inflammatory diseases, including steroid refractory acute graft versus host disease, acute respiratory distress syndrome, and biologic refractory inflammatory bowel disease; and Remestemcel-L, which is in Phase III clinical trials to treat chronic heart failure and chronic low back pain due to degenerative disc disease. It is also developing MPC-300-IV to treat biologic refractory rheumatoid arthritis diabetic nephropathy; and MPC-25-IC for the treatment or prevention of acute myocardial infarction. The company has strategic partnerships with Tasly Pharmaceutical Group to offer MPC-150-IM for heart failure and MPC-25-IC for heart attacks in China; JCR Pharmaceuticals Co. Ltd. to treat wound healing in patients with epidermolysis bullosa; and Grünenthal to develops and commercializes cell therapy for the treatment of chronic low back pain. Mesoblast Limited was incorporated in 2004 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.004747},{"month":2,"riseRate":0.454545,"avgChangeRate":0.029971},{"month":3,"riseRate":0.454545,"avgChangeRate":0.148159},{"month":4,"riseRate":0.454545,"avgChangeRate":0.155618},{"month":5,"riseRate":0.454545,"avgChangeRate":-0.026727},{"month":6,"riseRate":0.272727,"avgChangeRate":-0.081622},{"month":7,"riseRate":0.636364,"avgChangeRate":0.114172},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.033489},{"month":9,"riseRate":0.363636,"avgChangeRate":0.026673},{"month":10,"riseRate":0.545455,"avgChangeRate":-0.041459},{"month":11,"riseRate":0.727273,"avgChangeRate":0.082905},{"month":12,"riseRate":0.545455,"avgChangeRate":0.005342}],"exchange":"NASDAQ","name":"Mesoblast","nameEN":"Mesoblast","securityTypeName":"DR","adrRate":"1:10"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.1","shortVersion":"4.52.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mesoblast(MESO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mesoblast(MESO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mesoblast,MESO,Mesoblast股票,Mesoblast股票老虎,Mesoblast股票老虎国际,Mesoblast行情,Mesoblast股票行情,Mesoblast股价,Mesoblast股市,Mesoblast股票价格,Mesoblast股票交易,Mesoblast股票购买,Mesoblast股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mesoblast(MESO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mesoblast(MESO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}